According to a study published in the November 6, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology, older people who are sleepy during the day or lose interest in activities due to sleep issues may be more likely to develop a syndrome that can lead to dementia.
People with the syndrome walk slowly and report memory problems, but they do not have a mobility handicap or dementia. Motoric cognitive risk syndrome is a condition that can develop before dementia.
The study found that people with excessive daytime sleepiness and a lack of enthusiasm to get things done were more likely to develop the syndrome than people without those sleep-related issues. The study does not prove that these sleep-related issues cause the syndrome, it only shows an association.
“Our findings emphasize the need for screening for sleep issues,” said study author Victoire Leroy, MD, PhD, of Albert Einstein College of Medicine in the Bronx, New York. “There’s potential that people could get help with their sleep issues and prevent cognitive decline later in life.”
The study included 445 participants, with an average age of 76, who did not have dementia. Participants completed sleep surveys at the beginning of the trial. They were queried about memory problems, and their walking pace was measured on a treadmill at the beginning of the study and then once a year for the next three years.
The sleep assessment included questions about how frequently people had difficulties sleeping because they woke up in the middle of the night, couldn't fall asleep within 30 minutes, or felt too hot or cold, as well as whether they used sleep aids. The question to assess excessive daytime drowsiness asks how frequently people have had problems remaining awake when driving, eating meals, or were engaged in any other activity.
In total, 177 participants fit the category of bad sleepers, whereas 268 satisfied the definition of good sleepers.
At the outset of the trial, 42 participants had motoric cognitive risk syndrome. Throughout the trial, 36 more persons got the condition.
35.5% of patients who experienced extreme daytime sleepiness and a lack of enthusiasm developed the syndrome, compared to 6.7% who did not. After accounting for other factors that could influence the risk of the syndrome, such as age, depression, and other health conditions, researchers discovered that people with excessive daytime sleepiness and a lack of enthusiasm were more than three times more likely to develop the syndrome than those who did not have those sleep-related issues.
“More research needs to be done to look at the relationship between sleep issues and cognitive decline and the role played by motoric cognitive risk syndrome,” Leroy said. “We also need studies to explain the mechanisms that link these sleep disturbances to motoric cognitive risk syndrome and cognitive decline.”
A limitation of the study is that participants reported their own sleep information, so they may not have remembered everything accurately.
The study was supported by the National Institute on Aging.
Credit: iStock
A 30-year-old woman has shared how her kratom use spiraled from four capsules a day to 100, affecting her health, work and daily life. She initially believed the substance was safe because it was natural and legal.
Hilary Tesluck, from Michigan, first tried leaf kratom capsules in 2017, at age 21. A friend introduced her to the substance as an alternative to prescription medication she took for anxiety, she told Fox News Digital.
She started with four capsules, without clear dosing guidance.
Kratom initially boosted Tesluck's energy, confidence and productivity. But she gradually increased her intake to 100 capsules a day.
"Very slowly, over time, I had to take just one more capsule or just one more dose," she said. Her work performance suffered. She also lost nearly 40 pounds and became so physically weak that standing in the shower was difficult.
Although she had initially viewed kratom as harmless, she eventually recognized her dependence and sought help.
Also read: Doctors Call Kratom The ‘Next Addiction Crisis’ As More US States Push Bans
Tesluck first sought treatment in 2020 but said a urine test failed to detect kratom use. She found support through an online recovery group in 2021.
She relapsed in 2023 following her grandmother's death. Later, the deaths of her cat and the end of a relationship triggered another relapse, this time involving 7-OH.
7-OH, or 7-hydroxymitragynine, occurs naturally in trace amounts in kratom, but concentrated products contain much higher levels. The body also converts some of kratom's main active compound, mitragynine, into 7-OH. Both act on opioid receptors and can contribute to dependence, according to the FDA.
Tesluck described concentrated 7-OH as particularly potent and said she used it for a few months before returning to her recovery group and stopping.
"It's one problem at two strengths," she said of leaf kratom and 7-OH. She is now executive director of End Kratom Addiction, where she works to raise awareness and support people in recovery.
Read More: Mississippi Student Deaths Put Kratom Under Scrutiny: How Dangerous Is It?
Kratom-related reports to US poison centers increased about 1,200% between 2015 and 2025, reaching a record 3,434 in 2025, according to the Centers for Disease Control and Prevention (CDC).
Kratom regulations vary across the US, including age restrictions, product standards and bans.
Tesluck also warned that social media advertising and attractive packaging can make these products appear harmless and encourage people to try them. She said her work brings her into contact with parents who attribute their children's deaths to kratom products.
The FDA says no kratom drugs are approved by the agency. Kratom also cannot legally be marketed as a dietary supplement or added to conventional foods.
Tesluck said one warning sign is when kratom starts controlling daily routines, such as planning trips around shop hours or worrying about running out.
Other signs include reduced appetite, weight loss, hair loss, cravings and taking more than intended. Repeated unsuccessful attempts to stop and continued use despite problems at work or home are also signs of problematic use, according to the National Institute on Drug Abuse.
Experiencing discomfort or feeling worse when missing or reducing a dose was another sign she recalled.
Tesluck also described sedation, numbness and irritability. "I was kind of like a zombie shell of myself overall," she said, adding that her personality had changed and she had become irritable and mean.
Credit: Ai-generated image
Osteoarthritis has often been considered as a disease of old age, resulting from years of joint wear-and-tear and cartilage damage. But research is looking deeper into causes of the disease that go beyond what happens inside the joints.
One of the causes could be the trillions of microorganisms living in the gut, known as the gut microbiome. They are known to influence inflammation in the body and resultantly affect joint health.
Scientists are turning their attention towards the gut-joint axis, which may interconnect the gut bacteria, immune system and inflammation in joint tissues. While the relationship is still being studied, early observation says that changes in gut bacteria may influence how osteoarthritis develops.
Experts explain if poor gut health can increase the risk of arthritis and if improving gut microbiome can help protect the joints.
Osteoarthritis develops when the protective cartilage cushioning the ends of bones gradually breaks down. This can cause pain, stiffness, swelling and difficulty moving the affected joint.
Although physical strain and ageing are key drivers, inflammation and metabolic changes are also believed to influence the disease.
Dr Vaibhav Bagaria, Director, Orthopaedics and Joint Replacement at Sir H.N. Reliance Foundation Hospital told HealthandMe that understanding surrounding osteoarthritis has evolved over the years.
“In the past, osteoarthritis was thought to be a degenerative disease. But we now understand that it is a complex disease that involves inflammation, metabolism, aging and mechanical stress,” he explained.
Emerging research, however, suggests that the gut microbiome could be another factor influencing this process. Gut bacteria help with digestion, produce metabolites and interact with the immune system. Changes in their gut bacteria may influence inflammatory responses in different parts of the body, including the joints.
Dr Deepak Thakur, Principal Consultant, Orthopaedics and Joint Surgeon at Yatharth Super Speciality Hospital, Noida, told HealthandMe, “Studies have found associations between changes in gut bacteria and osteoarthritis, raising the possibility that the gut microbiome could influence the disease. But we are still learning how this relationship works, and we cannot yet say that changes in gut bacteria directly cause osteoarthritis.”
The relationship between gut bacteria, intestinal permeability and inflammation could explain this scenario. A healthy intestinal barrier regulates what enters the bloodstream while keeping harmful substances within the gut.
However, changes in the composition of gut bacteria may affect this barrier, increasing intestinal permeability. This is called a ‘leaky gut’.
When the intestinal barrier becomes more permeable, bacterial elements like lipopolysaccharides (LPS) may enter the bloodstream and trigger an immune response. This could contribute to low-grade inflammation throughout the body, which could affect cartilage, the synovium (the tissue lining the joints) and other joint structures.
Dr Bagaria explained, “Unhealthy gut flora could lead to increased intestinal permeability (or a ‘leaky gut’) that might cause entry of the bacterial components, like lipopolysaccharides, into the bloodstream causing systemic low-grade inflammation.”
However, gut bacteria may also have protective functions. Dr Bagaria added, “The healthy bacteria release the short-chain fatty acids that modulate immune response and might affect cartilage degeneration, synovial inflammation and sensitivity to pain.”
Talking to HealthandMe, Dr Debaditya Roy, Consultant Rheumatologist at CK Birla Hospitals, CMRI, Kolkata, also points to the possible role of microbial components and immune response.
“Changes in the composition of gut flora can result in an altered synthesis of microbial products. In turn, increased permeability of the intestine can allow pro-inflammatory substances to enter the bloodstream. Subsequently, certain pathways of immune response can be activated, which influence the cartilage tissue, synovium and subchondral bone tissues,” he explained.
Also read: Women And Arthritis: Why Risk Increases After 40
People with similar risk factors like age, body weight or previous joint injuries, do not experience osteoarthritis in the same way. Some may have considerable pain and mobility problems, while others with similar joint damage experience mild symptoms.
Differences in genetics, metabolism and inflammatory responses may explain this to some extent. Researchers are now exploring whether the gut microbiome could be another contributing factor.
Dr Bagaria highlights an observation from his practice: “It is intriguing that in orthopaedics two patients who have the same X-rays may experience different severity of pain and disability. These differences depend on genetics, obesity, metabolism and inflammatory response but the gut microbiome could be another factor.”
Different individuals have different compositions of gut bacteria, which may influence their metabolic and immune responses. Dr Roy believes the gut microbiome may help explain some of the differences between patients.
“The involvement of the intestinal microbiome may provide some explanation regarding the heterogeneity of progression rates of the disease among different patients despite similarity of their risk factors (such as age, BMI, history of trauma). Different microbial compositions may be present in one person’s intestine compared to another. Patients may have different immune responses as well as metabolic outcomes.”
Also read: Your Knees In Your 30s And 40s: Small Habits That Go A Long Way
An emerging area of research, diet and probiotics can influence joint health. Scientists are also exploring whether changes in gut bacteria could help alleviate inflammation and improve osteoarthritis symptoms. But for now there is no established evidence supporting the same.
Dr Bagaria said, “A high fibre diet with fruits, vegetables, whole grains and fermented foods is a healthy choice that benefits your metabolism and gut microbiome. Nevertheless, at the moment there is not enough evidence to suggest specific probiotics or microbiome interventions for osteoarthritis.”
Dr Thakur stated that early clinical studies have shown some promise but the findings are not enough to support this. “We need larger, well-designed clinical trials to establish their safety, effectiveness and appropriate use. For now, patients should not replace their prescribed treatment with probiotics or supplements,” he said.
Dr Roy also emphasises that dietary changes and microbiome-based interventions cannot currently be considered arthritis therapies.
“A balanced and high-fibre diet may help improve one’s general well-being. However, this cannot be used as arthritis treatment.”
Credit: AI-generated image
The type of flu vaccine older adults receive also has effects on their brain health. A study published in the journal Neurology has found that adults aged 65 and above who received a high-dose influenza vaccine had a lower risk of developing Alzheimer's disease compared to those who received a standard dose shot.
The research, led by scientists at the University of Texas Health Science Center at Houston (UTHealth Houston), suggests that the higher-dose vaccine may offer an additional benefit in addition to protection against influenza.
The effect was observed for up to 25 months after vaccination. The study reported nearly 55% lower risk of Alzheimer's linked with high-dose flu vaccination.
Also read: US Flu Cases Rising: What To Know About The New G155E H1N1 Mutation
Researchers analysed US healthcare claims data from adults aged 65 and older who received either a high-dose or standard-dose influenza vaccine between 2014 and 2019.
The study included 120,775 people who received high-dose vaccines and 44,022 who received standard-dose vaccines. Participants were followed for up to three years to examine the risk of Alzheimer's disease.
The researchers found that people who received the high-dose vaccine had a significantly lower risk of developing Alzheimer's compared to those who received the standard dose. The effect of the flu shot sustained for approximately 25 months in the primary analysis. The link between high-dose flu vaccination and lower Alzheimer's risk lasted longer among women than men.
An earlier study by the same research group, published in 2022, had found that older adults who received an influenza vaccine had approximately 40% lower risk of developing Alzheimer's disease than those who did not receive the vaccine. The latest research examined whether a higher vaccine dose could help with an additional reduction in risk.
Also read: New COVID-19 Variant PJ.2.1 Spreads Globally: WHO Says Symptoms Resemble Cold, Flu
High-dose influenza vaccines are designed to generate a stronger immune response. They contain four times the amount of influenza antigen found in standard-dose vaccines.
As people age, their immune systems may become less effective in responding to infections. A stronger vaccine formulation is therefore intended to improve protection against influenza in older adults.
Paul Schulz, professor of neurology at McGovern Medical School and senior author of the study, explained how the research idea emerged, “The public health department had seen our vaccine research and asked if I could come down to talk to them about it,” Schulz said. “We went through the findings, and they asked if there was a difference with different dosages; I was confused.”
He also recalled, “I was stunned that, as a physician, I didn’t know a higher dose was offered.”
Researchers have offered several possible explanations. Better protection against influenza could reduce severe infections and the inflammation that accompanies them. Another possibility is that stronger immune response fights inflammatory processes involved in Alzheimer's disease.
The study was retrospective and observational meaning researchers examined existing healthcare records rather than randomly assigning participants to receive different vaccine doses.
Although statistical methods were used to account for differences between the groups, other factors could still have influenced the results.
The researchers also noted that Alzheimer's disease develops over many years before symptoms become apparent. The study's follow-up period of up to three years is therefore too short to establish whether vaccination prevents the underlying disease or delays the appearance of symptoms.
© $2026 Times Horizon Private Limited